Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
ACTH ELISA Kit (AC3069)
Cat.#: ASET-1658
Specifications
Description ACTH ELISA Kit is a competitive Enzyme-Linked Immunosorbent Assay (cELISA) designed for the in vitro quantitative determination of ACTH concentrations in serum, plasma, tissue homogenates, and other biological fluids. The kit employs the sandwich enzyme immunoassay technique. Size 96T Sample Type Serum, plasma, tissue homogenates, and other biological fluids. Reactivity Universal Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 9.375 pg/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 12.5-800 pg/mL Assay Time 4h 30m Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-1393 Human Synaptophysin ELISA Kit (AC2804) Quantitative inquiry ASET-1809 Human Ephrin B2 ELISA Kit (AC3220) Quantitative inquiry ASET-2090 Human PCDHB16 ELISA Kit (AC3501) Quantitative inquiry ASET-1016 Rat EDG8 ELISA Kit (AC2427) Quantitative inquiry ASET-1470 Human GCH1 ELISA Kit (AC2881) Quantitative inquiry ASET-1532 Rat CaMKII beta ELISA Kit (AC2943) Quantitative inquiry ASET-1701 Rat CACNA1A ELISA Kit (AC3112) Quantitative inquiry ASET-2390 Human CCR5 ELISA Kit (AC3801) Quantitative inquiry ASET-1759 Human FGFR1 ELISA Kit (AC3170) Quantitative inquiry ASET-1880 Human SOX9 ELISA Kit (AC3291) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket